HODGKINS-DISEASE - VALUE OF PROGNOSTIC CRITERIA AND OF COMBINATION OF RADIOTHERAPY AND CHEMOTHERAPY IN LOCALIZED LYMPHOID STAGE-1 AND STAGE-II - 94 PATIENTS UNDERGOING LAPAROTOMY

被引：0
|
作者：
BERNADOU, A
BLANC, CM
JAMES, JM
DAO, C
ZITTOUN, R
BILSKIPASQUIER, G
机构：
来源：
NOUVELLE PRESSE MEDICALE | 1978年 / 7卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：807 / 812
页数：6
相关论文
共 50 条
  • [41] A RANDOMIZED TRIAL OF 2 TYPES OF ADJUVANT CHEMOTHERAPY IN RADIOTHERAPY-TREATED PATIENTS WITH CLINICAL STAGE-I AND STAGE-II HIGH-GRADE NON-HODGKINS-LYMPHOMA
    WAGSTAFF, J
    TODD, I
    DEAKIN, D
    WILKINSON, P
    SCARFFE, JH
    HARRIS, M
    JONES, M
    CROWTHER, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (01) : 53 - 58
  • [42] TREATMENT OF PATIENTS (PT) WITH STAGE-I AND STAGE-II HODGKINS-DISEASE (HD) - INVOLVED FIELD (IFXRT) VERSUS EXTENDED FIELD (EFXRT) VERSUS IFXRT FOLLOWED BY 6 MOPP
    HAGEMEISTER, FB
    FULLER, LM
    SULLIVAN, JA
    VELASQUEZ, WS
    BUTLER, JJ
    SHULLENBERGER, CC
    CANCER TREATMENT REPORTS, 1982, 66 (04): : 1058 - 1058
  • [43] THE MANAGEMENT OF STAGE-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE AT ST-BARTHOLOMEWS-HOSPITAL - A RETROSPECTIVE REVIEW OF 114 PREVIOUSLY UNTREATED PATIENTS OVER 14 YEARS
    DORREEN, MS
    WRIGLEY, PFM
    LAIDLOW, JM
    PLOWMAN, PN
    NEUDACHIN, L
    TUCKER, AK
    MALPAS, JS
    STANSFELD, AG
    FAUX, MMML
    JONES, AE
    LISTER, TA
    CANCER, 1984, 54 (12) : 2882 - 2888
  • [44] LACK OF PROGNOSTIC VALUE OF HISTOPATHOLOGIC PARAMETERS IN HODGKINS-DISEASE, NODULAR SCLEROSIS TYPE - A STUDY OF 123 PATIENTS WITH LIMITED STAGE DISEASE WHO HAD UNDERGONE LAPAROTOMY AND WERE TREATED WITH RADIATION-THERAPY
    DAMORE, ESG
    LEE, CKK
    AEPPLI, DM
    LEVITT, SH
    FRIZZERA, G
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1992, 116 (08) : 856 - 861
  • [45] COMBINED CHEMOTHERAPY-RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE - RESULTS OF A PROSPECTIVE CLINICAL-TRIAL WITH 70 STAGE IIIB-IV PATIENTS
    FERME, C
    LEPAGE, E
    BRICE, P
    DAGAY, MF
    FERMAND, JP
    CASTAIGNE, S
    FRIJA, J
    MIOT, C
    MARTY, M
    GISSELBRECHT, C
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (03): : 397 - 405
  • [46] HODGKINS-DISEASE, CLINICAL STAGE-1A AND STAGE-IIIB (173 PATIENTS) - ASSOCIATION OF SHORT-TERM CHEMOTHERAPY (3-MOPP OR 3-CVBPP) + RADIOTHERAPY - RESULTS AT 7 YEARS
    ANDRIEU, JM
    COSCAS, Y
    CRAMER, P
    JULIEN, C
    JACQUILLAT, C
    WEIL, M
    BULLETIN DU CANCER, 1984, 71 (03) : 232 - 233
  • [47] INTENSIVE CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR THE TREATMENT OF ADVANCED-STAGE HODGKINS-DISEASE IN PEDIATRIC-PATIENTS - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    WEINER, MA
    LEVENTHAL, BG
    MARCUS, R
    BRECHER, M
    TERNBERG, J
    BEHM, FG
    CANTOR, A
    WHARAM, M
    CHAUVENET, A
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) : 1591 - 1598
  • [48] LONG-TERM FOLLOW-UP OF COMBINATION CHEMOTHERAPY-RADIOTHERAPY OF STAGE III HODGKINS-DISEASE - CANCER AND ACUTE-LEUKEMIA GROUP-B STUDY
    HOOGSTRATEN, B
    GLIDEWELL, O
    HOLLAND, JF
    BLOM, J
    STUTZMAN, L
    NISSEN, NI
    PERLBERG, HJ
    KRAMER, S
    CANCER, 1979, 43 (04) : 1234 - 1244
  • [49] NEOADJUVANT CHEMOTHERAPY (CT) AND RADIOTHERAPY (RT) VERSUS RADIOTHERAPY ALONE FOR SUPRADIAPHRAGMATIC CLINICAL STAGE-I-II HODGKINS-DISEASE (CS-I-II HD) PATIENTS WITH UNFAVORABLE PROGNOSTIC FACTORS - THE EORTC STUDY IN 257 PATIENTS (H-5 TRIAL, 1977-1982)
    CARDE, P
    HAYAT, M
    COSSET, JM
    HENRYAMAR, M
    AMIEL, JL
    TUBIANA, M
    CANCER DRUG DELIVERY, 1986, 3 (01): : 86 - 86
  • [50] Prognostic value of non-alcoholic fatty liver disease in stage II/III breast cancer patients who received neoadjuvant chemotherapy
    Yang, Y.
    Lee, K-H
    Kim, T-Y
    Han, S-W
    Oh, D-Y
    Kim, T-Y
    Han, W.
    Moon, H-G
    Park, I. A.
    Noh, D-Y
    Im, S-A
    CANCER RESEARCH, 2016, 76
12345